StockNews.com Initiates Coverage on Arcadia Biosciences (NASDAQ:RKDA)

StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research report issued to clients and investors on Monday. The firm set a “sell” rating on the basic materials company’s stock.

Separately, HC Wainwright restated a “buy” rating and issued a $6.00 price target on shares of Arcadia Biosciences in a research note on Wednesday, August 21st.

Arcadia Biosciences Price Performance

RKDA stock opened at $6.40 on Monday. The company has a market cap of $8.70 million, a P/E ratio of -1.50 and a beta of 1.19. Arcadia Biosciences has a 1 year low of $1.85 and a 1 year high of $10.31. The stock’s fifty day moving average price is $3.56 and its 200-day moving average price is $3.15.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.